386 related articles for article (PubMed ID: 15564453)
21. Low pH is required for avian sarcoma and leukosis virus Env-induced hemifusion and fusion pore formation but not for pore growth.
Melikyan GB; Barnard RJ; Markosyan RM; Young JA; Cohen FS
J Virol; 2004 Apr; 78(7):3753-62. PubMed ID: 15016895
[TBL] [Abstract][Full Text] [Related]
22. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex.
Bosch BJ; van der Zee R; de Haan CA; Rottier PJ
J Virol; 2003 Aug; 77(16):8801-11. PubMed ID: 12885899
[TBL] [Abstract][Full Text] [Related]
23. The fusion protein core of measles virus forms stable coiled-coil trimer.
Zhu J; Zhang CW; Qi Y; Tien P; Gao GF
Biochem Biophys Res Commun; 2002 Dec; 299(5):897-902. PubMed ID: 12470664
[TBL] [Abstract][Full Text] [Related]
24. The fusion core complex of the peste des petits ruminants virus is a six-helix bundle assembly.
Rahaman A; Srinivasan N; Shamala N; Shaila MS
Biochemistry; 2003 Feb; 42(4):922-31. PubMed ID: 12549911
[TBL] [Abstract][Full Text] [Related]
25. Molecular determinants of antiviral potency of paramyxovirus entry inhibitors.
Porotto M; Carta P; Deng Y; Kellogg GE; Whitt M; Lu M; Mungall BA; Moscona A
J Virol; 2007 Oct; 81(19):10567-74. PubMed ID: 17652384
[TBL] [Abstract][Full Text] [Related]
26. The central proline of an internal viral fusion peptide serves two important roles.
Delos SE; Gilbert JM; White JM
J Virol; 2000 Feb; 74(4):1686-93. PubMed ID: 10644338
[TBL] [Abstract][Full Text] [Related]
27. Fusion intermediates of HIV-1 gp41 as targets for antibody production: design, synthesis, and HR1-HR2 complex purification and characterization of generated antibodies.
Mzoughi O; Gaston F; Granados GC; Lakhdar-Ghazal F; Giralt E; Bahraoui E
ChemMedChem; 2010 Nov; 5(11):1907-18. PubMed ID: 20922745
[TBL] [Abstract][Full Text] [Related]
28. Design and characterization of viral polypeptide inhibitors targeting Newcastle disease virus fusion.
Zhu J; Jiang X; Liu Y; Tien P; Gao GF
J Mol Biol; 2005 Dec; 354(3):601-13. PubMed ID: 16253271
[TBL] [Abstract][Full Text] [Related]
29. Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoprotein.
Matsuyama S; Delos SE; White JM
J Virol; 2004 Aug; 78(15):8201-9. PubMed ID: 15254191
[TBL] [Abstract][Full Text] [Related]
30. C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.
Medinas RJ; Lambert DM; Tompkins WA
J Virol; 2002 Sep; 76(18):9079-86. PubMed ID: 12186891
[TBL] [Abstract][Full Text] [Related]
31. The spacing between cysteines two and three of the LDL-A module of Tva is important for subgroup A avian sarcoma and leukosis virus entry.
Rai T; Marble D; Rihani K; Rong L
J Virol; 2004 Jan; 78(2):683-91. PubMed ID: 14694099
[TBL] [Abstract][Full Text] [Related]
32. Alanine scanning mutagenesis of HIV-1 gp41 heptad repeat 1: insight into the gp120-gp41 interaction.
Sen J; Yan T; Wang J; Rong L; Tao L; Caffrey M
Biochemistry; 2010 Jun; 49(24):5057-65. PubMed ID: 20481578
[TBL] [Abstract][Full Text] [Related]
33. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41.
Joshi SB; Dutch RE; Lamb RA
Virology; 1998 Aug; 248(1):20-34. PubMed ID: 9705252
[TBL] [Abstract][Full Text] [Related]
34. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
Gallo SA; Sackett K; Rawat SS; Shai Y; Blumenthal R
J Mol Biol; 2004 Jun; 340(1):9-14. PubMed ID: 15184018
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of avian retroviral host range extension.
Rainey GJ; Natonson A; Maxfield LF; Coffin JM
J Virol; 2003 Jun; 77(12):6709-19. PubMed ID: 12767991
[TBL] [Abstract][Full Text] [Related]
36. The hydrophobic pocket contributes to the structural stability of the N-terminal coiled coil of HIV gp41 but is not required for six-helix bundle formation.
Dwyer JJ; Hasan A; Wilson KL; White JM; Matthews TJ; Delmedico MK
Biochemistry; 2003 May; 42(17):4945-53. PubMed ID: 12718536
[TBL] [Abstract][Full Text] [Related]
37. Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus.
Sun Y; Zhang H; Shi J; Zhang Z; Gong R
Viruses; 2017 Sep; 9(9):. PubMed ID: 28906430
[TBL] [Abstract][Full Text] [Related]
38. Six-helix bundle assembly and analysis of the central core of mumps virus fusion protein.
Liu Y; Zhu J; Feng MG; Tien P; Gao GF
Arch Biochem Biophys; 2004 Jan; 421(1):143-8. PubMed ID: 14678795
[TBL] [Abstract][Full Text] [Related]
39. Mutations in the fusion peptide and adjacent heptad repeat inhibit folding or activity of the Newcastle disease virus fusion protein.
Sergel TA; McGinnes LW; Morrison TG
J Virol; 2001 Sep; 75(17):7934-43. PubMed ID: 11483738
[TBL] [Abstract][Full Text] [Related]
40. Coronavirus escape from heptad repeat 2 (HR2)-derived peptide entry inhibition as a result of mutations in the HR1 domain of the spike fusion protein.
Bosch BJ; Rossen JW; Bartelink W; Zuurveen SJ; de Haan CA; Duquerroy S; Boucher CA; Rottier PJ
J Virol; 2008 Mar; 82(5):2580-5. PubMed ID: 18077706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
